Epidemics of vascular toxicity and pulmonary hypertension: what can be learned?
- 1 January 2000
- journal article
- review article
- Published by Wiley in Journal of Internal Medicine
- Vol. 247 (1) , 11-17
- https://doi.org/10.1046/j.1365-2796.2000.00586.x
Abstract
Egermayer P (Canterbury Respiratory Research Group, Christchurch, New Zealand). Epidemics of vascular toxicity and pulmonary hypertension: what can be learned? (Review). J Intern Med 2000; 247: 11–17.Epidemics of vascular disease caused by toxins and infectious agents affecting both humans and animals have been common in history. Examples of agents implicated include anorexients, ergotamine, mercury, arsenic, vinyl chloride, thorotrast, plant alkaloids, nitrites, toxic oil, tryptophan and bacterial, viral and parasitic infections. A major characteristic of these disorders is endothelial dysfunction, which may manifest itself in vasospastic disorders, sclerodermiform skin lesions, fibrosis, osteolytic lesions, polyneuropathy and portal and pulmonary hypertension. Angiosarcoma may also be a late outcome. These diseases are more common than is generally appreciated. The aetiology is usually multifactorial. This and other factors contribute to delayed recognition.Keywords
This publication has 64 references indexed in Scilit:
- Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertensionThorax, 1999
- Anorectic drugs and valvular heart disease: A biological and clinical perspectiveCleveland Clinic Journal of Medicine, 1998
- Digital Necrosis Associated with DexfenfluramineNew England Journal of Medicine, 1997
- Valvular Heart Disease Associated with Fenfluramine–PhentermineNew England Journal of Medicine, 1997
- Brain Serotonin Neurotoxicity and Primary Pulmonary Hypertension From Fenfluramine and DexfenfluramineJAMA, 1997
- Appetite suppressants and pulmonary hypertensionThorax, 1997
- Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infectionPublished by Elsevier ,1997
- Obesity, dexfenfluramine, and pulmonary hypertension. A lesson not learned?American Journal of Respiratory and Critical Care Medicine, 1997
- Chronic Pulmonary Hypertension in Sheep: Temporal Progression of LesionsJournal of Surgical Research, 1996
- Primary pulmonary hypertension and fenfluramine use.Heart, 1993